Menu
Back to User profile » Dr Dian-zhong Luo
Papers published by Dr Dian-zhong Luo:
MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays
Gao L, Xiong D, He R, Yang X, Lai Z, Liu L, Huang Z, Wu H, Yang L, Ma J, Li S, Lin P, Yang H, Luo D, Dang Y, Chen G
OncoTargets and Therapy 2019, 12:9827-9848
Published Date: 18 November 2019
MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1
Chen ZM, Yu Q, Chen G, Tang RX, Luo DZ, Dang YW, Wei DM
Cancer Management and Research 2019, 11:4825-4837
Published Date: 27 May 2019
Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases
Xie ZC, Dang YW, Wei DM, Chen P, Tang RX, Huang Q, Liu JH, Luo DZ
OncoTargets and Therapy 2017, 10:3991-4005
Published Date: 10 August 2017
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma
Liang HW, Ye ZH, Yin SY, Mo WJ, Wang HL, Zhao JC, Liang GM, Feng ZB, Chen G, Luo DZ
OncoTargets and Therapy 2017, 10:3405-3419
Published Date: 11 July 2017
Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis
Li JJ, Liang L, Liu YR, Luo YH, Liang XN, Luo DZ, Feng ZB, Dang YW, Yang LH, Chen G
OncoTargets and Therapy 2016, 9:1721-1734
Published Date: 21 March 2016